Exchange: NASDAQ·Updated 07:49 PM EDT
SION logo

SION Sionna Therapeutics Inc

$7.18
$0.43
(6.37%)
Today
Closed $7.18
$0.05
(0.70%)
After Hours
Reported EarningsAug 6
Mkt Cap$324.63M
Vol926,066.00

About SION

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
40

Bearish Sentiment

How do you feel about SION?

Advertisement|Remove ads.